Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...
Exploring new treatment avenues has become crucial as mental health challenges such as depression and PTSD continue impacting ...
Management of PTSD may involve the use of various treatment modalities, involving both nondrug treatments and pharmacotherapy. Nondrug treatment is regarded as the first-line option for PTSD and ...
The synergistic relationship between psychiatric medications and psychotherapy is often overlooked. By managing discreet ...
Johnson & Johnson has announced a major breakthrough in mental health treatment. The Food and Drug Administration (FDA) has approved Spravato, a novel nasal spray, for the standalone treatment of ...
for PTSD. Psilocybin, the psychoactive ingredient in hallucinogenic (or ‘magic’) mushrooms, can also be given to those with treatment resistant depression (TRD). The two drugs have now been ...
Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...
PTSD is a serious medical condition that affects ... “Decades of hard work in a new field of mental health treatment has led to efficacy rates that are so high that it’s safe to say that ...
TMS safety, accelerated 5-day treatment options, and therapy costs are explained by Inspire TMS Denver. Broomfield, Colorado- ...
Feelings of sadness or irritability that last a month or more after a life-threatening event could be signs of acute stress ...